X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
35
PharmaCompass offers a list of Doxofylline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Doxofylline manufacturer or Doxofylline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Doxofylline manufacturer or Doxofylline supplier.
PharmaCompass also assists you with knowing the Doxofylline API Price utilized in the formulation of products. Doxofylline API Price is not always fixed or binding as the Doxofylline Price is obtained through a variety of data sources. The Doxofylline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Doxofylline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxofylline, including repackagers and relabelers. The FDA regulates Doxofylline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxofylline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Doxofylline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Doxofylline supplier is an individual or a company that provides Doxofylline active pharmaceutical ingredient (API) or Doxofylline finished formulations upon request. The Doxofylline suppliers may include Doxofylline API manufacturers, exporters, distributors and traders.
click here to find a list of Doxofylline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Doxofylline DMF (Drug Master File) is a document detailing the whole manufacturing process of Doxofylline active pharmaceutical ingredient (API) in detail. Different forms of Doxofylline DMFs exist exist since differing nations have different regulations, such as Doxofylline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Doxofylline DMF submitted to regulatory agencies in the US is known as a USDMF. Doxofylline USDMF includes data on Doxofylline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Doxofylline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Doxofylline suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Doxofylline Drug Master File in Korea (Doxofylline KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Doxofylline. The MFDS reviews the Doxofylline KDMF as part of the drug registration process and uses the information provided in the Doxofylline KDMF to evaluate the safety and efficacy of the drug.
After submitting a Doxofylline KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Doxofylline API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Doxofylline suppliers with KDMF on PharmaCompass.
A Doxofylline written confirmation (Doxofylline WC) is an official document issued by a regulatory agency to a Doxofylline manufacturer, verifying that the manufacturing facility of a Doxofylline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Doxofylline APIs or Doxofylline finished pharmaceutical products to another nation, regulatory agencies frequently require a Doxofylline WC (written confirmation) as part of the regulatory process.
click here to find a list of Doxofylline suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Doxofylline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Doxofylline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Doxofylline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Doxofylline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Doxofylline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Doxofylline suppliers with NDC on PharmaCompass.
Doxofylline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Doxofylline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Doxofylline GMP manufacturer or Doxofylline GMP API supplier for your needs.
A Doxofylline CoA (Certificate of Analysis) is a formal document that attests to Doxofylline's compliance with Doxofylline specifications and serves as a tool for batch-level quality control.
Doxofylline CoA mostly includes findings from lab analyses of a specific batch. For each Doxofylline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Doxofylline may be tested according to a variety of international standards, such as European Pharmacopoeia (Doxofylline EP), Doxofylline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Doxofylline USP).
Market Place
